VÉLIZY , France and WASHINGTON —- Dassault Systèmes (Euronext Paris:

#13065, DSY.PA), the 3DEXPERIENCE Company, world leader in 3D design software, 3D

Digital Mock Up and Product Lifecycle Management (PLM) solutions, today announced the

introduction of its newest brand, BIOVIA. The new brand is a combination of Dassault

Systèmes’ own activities in BioIntelligence, its collaborative 3DEXPERIENCE technologies, and

the leading life sciences and material sciences applications from the recent acquisition of

Accelrys. The newly acquired company’s solutions focus on biological, chemical and materials

modeling and simulation, research and open collaborative discovery, enterprise laboratory and

quality management, and process manufacturing intelligence. Today’s announcement was

made at Accelrys’ Accelerate 2014 user conference in Washington, D.C.

Dassault Systèmes’ BIOVIA is now the largest and deepest portfolio for the biological, chemical

and material modeling, simulation and production domains. BIOVIA’s list of 2,000+ customers

includes numerous Fortune 500 companies, such as Sanofi, Pfizer, GSK, AstraZeneca, Du

Pont, Shell, BASF, P&G, Unilever and L’Oréal.

BIOVIA will provide enterprise-wide scientific, biological, chemical and material experiences,

with next-generation applications, services, and content access and delivery leveraging

Dassault Systèmes’ 3DEXPERIENCE business platform. From material design to molecular

simulation to chemical manufacturing, it is Dassault Systèmes’ vision that BIOVIA will act as a

disruptive catalyst to deliver virtual scientific universes capable of harmonizing products, nature

and life.

“Today is an important day for Dassault Systèmes and one which I, personally, have been

looking forward to for several years. Dassault Systèmes’ previous research programs in life

sciences and BioIntelligence were precursors to today’s new brand and capabilities,” said

Bernard Charlès, President & CEO, Dassault Systèmes. “The integration of Accelrys’ powerful

applications with our 3DEXPERIENCE platform will create a new collaborative environment for

advanced biological, chemical and materials experience development. With the power of

BIOVIA, we will model the entire biosphere.”

The integration of the company’s 3DEXPERIENCE platform with Accelrys’ strong suite of

applications opens up a wide opportunity to support and develop systemic collaboration, project

management, data and content reuse, traceability, and other processes, applications and

integrations that are absolutely critical to scientific industries, including pharmaceutical

companies that are facing significant innovation and drug discovery challenges.

“Accelrys’ strategy is to provide customers with solutions and tools that will enable them to

optimize the scientific innovation lifecycle from discovery to commercialization,” said Dick Slansky, Senior Analyst PLM & Industry at ARC Advisory Group. “The acquisition of Accelrys by

Dassault Systèmes will make the Accelrys scientific innovation platform available to enrich

Dassault Systèmes’ molecular chemistry capabilities in the life sciences, CPG and

manufacturing industry sectors.”

“Our ambition is to provide industry and science the apps necessary to model the biosphere.

BIOVIA brings an enterprise-wide, systemic collaborative approach to enable innovation for

pharmaceutical, CPG and other process-based industries,” said Max Carnecchia, CEO, BIOVIA,

Dassault Systèmes. “The sophisticated enterprise system of modeling, simulation, and

laboratory and quality management enables innovation for almost every industry.”

Aside from key innovators and leaders in the pharmaceutical and biotech industries, leading

manufacturing companies, including Boeing, Toyota, Samsung and others, are using BIOVIA

solutions to explore and bring to market new materials, such as smart coatings, lighter, stronger

composites, and ecosustainable material innovations.

Such companies are fast approaching the point of using material as a variable, not a constraint.

To do so, the ability to manage product information at the molecular level in a scalable manner

is essential throughout the value chain. In addition, today’s aggressive industrialization of

research, development and manufacturing processes is driving the adoption of an integrated

business platform capable of handling diverse information types in collaborative and compliant

environments.

“PLM software users focused on commercialization and new product introduction will be

exposed to R&D tools that expand product innovation and multichannel opportunities,” wrote

Michael Shanler, Research Director at Gartner. For further information, refer to Gartner

Research Report G00262297, “Dassault Adds Scientific and Lab Informatics Power with

Accelrys.”

For further information, please visit https://www.3ds.com/biovia.

###

About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE Company, provides business and people with virtual universes to imagine

sustainable innovations. Its world-leading solutions transform the way products are designed, produced, and

supported. Dassault Systèmes’ collaborative solutions foster social innovation, expanding possibilities for the virtual

world to improve the real world. The group brings value to over 190,000 customers of all sizes, in all industries, in

more than 140 countries. For more information, visit www.3ds.com.

CATIA, SOLIDWORKS, ENOVIA, DELMIA, SIMULIA, GEOVIA, EXALEAD, 3D VIA, 3DSWYM, BIOVIA, NETVIBES,

3DXCITE are registered trademarks of Dassault Systèmes or its subsidiaries in the US and/or other countries.